Growth Metrics

InspireMD (NSPR) Accumulated Expenses (2012 - 2025)

InspireMD posted quarterly Accumulated Expenses of $1.5 million for Q4 2025, up 16.6% year-on-year from $1.3 million in Q4 2024, and up 110.2% on a QoQ basis from $735000.0 in Q3 2025.

InspireMD (NSPR) has 14 years of Accumulated Expenses data on file, last reported at $1.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 16.6% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 16.6% YoY), and the FY2025 full-year result was $1.5 million, up 16.6% from the prior year.
  • Accumulated Expenses for Q4 2025 stood at $1.5 million, up from $735000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.2 million in Q4 2023 and bottomed at $233000.0 in Q4 2021.
  • The 5-year median for Accumulated Expenses is $918500.0 (2025), against an average of $891200.0.
  • The widest annual swing landed in 2021, when Accumulated Expenses surged 2046.67%; it then slumped 77.42% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $233000.0 in 2021, then surged by 137.77% to $554000.0 in 2022, then soared by 294.95% to $2.2 million in 2023, then sank by 39.44% to $1.3 million in 2024, then rose by 16.6% to $1.5 million in 2025.
  • The last three Accumulated Expenses figures came in at $1.5 million (Q4 2025), $735000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.55 Mn
Sep 30, 2025 735,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 821,000.00
Dec 31, 2024 1.33 Mn
Sep 30, 2024 401,000.00
Jun 30, 2024 384,000.00
Mar 31, 2024 1.10 Mn
Dec 31, 2023 2.19 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.26 Mn
Mar 31, 2023 240,000.00
Dec 31, 2022 554,000.00
Sep 30, 2022 1.43 Mn
Jun 30, 2022 287,000.00
Mar 31, 2022 1.06 Mn
Dec 31, 2021 233,000.00
Sep 30, 2021 332,000.00
Jun 30, 2021 1.02 Mn
Mar 31, 2021 322,000.00
Dec 31, 2020 278,000.00
Jun 30, 2020 278,000.00
Mar 31, 2020 15,000.00
Dec 31, 2019 188,000.00
Sep 30, 2019 439,000.00
Jun 30, 2019 509,000.00
Mar 31, 2019 184,000.00
Dec 31, 2018 828,000.00
Sep 30, 2018 162,000.00
Jun 30, 2018 590,000.00
Mar 31, 2018 855,000.00
Dec 31, 2017 165,000.00
Sep 30, 2017 133,000.00
Jun 30, 2017 437,000.00
Mar 31, 2017 65,000.00
Dec 31, 2016 56,000.00
Sep 30, 2016 433,000.00
Jun 30, 2016 54,000.00
Dec 31, 2015 80,000.00
Jun 30, 2015 731,000.00
Dec 31, 2014 410,000.00
Jun 30, 2014 1.01 Mn
Mar 31, 2014 727,000.00
Dec 31, 2013 886,000.00
Sep 30, 2013 1.05 Mn
Jun 30, 2013 1.34 Mn
Mar 31, 2013 1.56 Mn
Dec 31, 2012 841,000.00
Sep 30, 2012 1.26 Mn
Jun 30, 2012 1.20 Mn